Background. The role of seasonal variation in peritoneal dialysis (PD)-related peritonitis has been limited to a few small single-centre studies. Methods. Using all 6610 Australian patients receiving PD between 1 October 2003 and 31 December 2008, we evaluated the influence of seasons on peritonitis rates (Poisson regression) and outcomes (multivariable logistic regression). Results. The overall rate of peritonitis was 0.59 episodes per patient-year of treatment. Using winter as the reference season, the peritonitis incidence rate ratios (95% confidence interval) for summer, autumn and spring were 1.02 Ó The Author 2011. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com (0.95-1.09), 1.01 (0.94-1.08) and 0.99 (0.92-1.06), respectively. Significant seasonal variations were observed in the rates of peritonitis caused by coagulase-negative Staphylococci (spring and summer peaks), corynebacteria (winter peak) and Gram-negative organisms (summer and autumn peaks). There were trends to seasonal variations in fungal peritonitis (summer and autumn peaks) and pseudomonas peritonitis (summer peak). No significant seasonal variations were observed for other organisms. Peritonitis outcomes did not significantly vary according to season. Conclusions. Seasonal variation has no appreciable influence on overall PD peritonitis rates or clinical outcomes. Nevertheless, significant seasonal variations were observed in the rates of peritonitis due to specific microorganisms, which may allow institutions to more precisely target infection control strategies prior to higher risk seasons.
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Introduction
Peritonitis is a serious complication of peritoneal dialysis (PD), responsible for significant morbidity, and accounting for 30% of technique failures and 21% of infectious deaths in Australian and New Zealand PD patients [1, 2] . Studies on organism-specific peritonitis [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] have identified the frequency, predictors, treatment and clinical outcomes of these infections. However, the role of seasonal variation on peritonitis frequency, microbiology and clinical outcomes has not been examined in detail.
Changes in temperature and humidity that accompany changes in season may potentially play a role in the development of PD peritonitis by influencing the behaviour and hygiene of patients, the distribution of normal skin flora and the chance of contamination. However, findings from previous small studies have been conflicting, with some showing higher peritonitis rates in the warmer seasons [15] [16] [17] [18] , while others showed no such relationship [19] . These investigations have generally been limited by small patient numbers from a single-centre retrospective design, sometimes inappropriate statistical analyses and relatively narrow ranges of temperature and humidity in the studied regions that are often within one climatic zone, thereby possibly underestimating the true effect of seasonal variation.
The aim of the current study was to undertake a comprehensive multi-centre examination of the influence of season on peritonitis frequency, microbiology and clinical outcomes in all Australian PD patients, as recorded in the Australia and New Zealand dialysis and transplant (ANZDATA) registry.
Materials and methods

Study population
The study included all Australian adult patients from the ANZDATA Registry who were receiving PD between 1 October 2003 (when detailed peritonitis data started to be collected) and 31 December 2008. The data collected included demographic data, cause of primary renal disease, comorbidities at the start of dialysis, smoking status, body mass index (BMI), late referral (defined as commencement of dialysis within 3 months of referral to a nephrologist), microbiology of peritonitis episodes (up to three organisms for polymicrobial episodes) and the initial and subsequent antibiotic treatment regimens. The data were collected throughout the calendar year by medical and nursing staff in each renal unit and submitted annually to the ANZDATA Registry by the end of March in the following year.
Peritonitis rates, microbiology and outcomes were assessed according to season of occurrence. Seasons for Australia were defined as follows: Summer (December, January and February), Autumn (March, April and May), Winter (June, July and August) and Spring (September, October and November). Average daily maximum temperatures and rainfall measurements vary considerably across Australia between seasons: January (22-36°C, 13-500 mm/month), April (18-28°C, 24-130 mm/month), July (12-21°C, 1-154 mm/month) and October (17-31°C, 23-348 mm/month) (http://www.abs.gov.au/ausstats/abs@.nsf/mf/1301.0). Subgroup analyses of overall and organism-specific peritonitis incidence rate ratios (IRRs) for PD patients living in tropical regions (n ¼ 411) and temperate regions (n ¼ 4236) of Australia were also performed to determine whether seasonal variations were more prominent at the extremes of climate. Tropical and temperate regions were defined according to the Köppen classification scheme used by the Australian Bureau of Meteorology (http://www.bom.gov.au). Peritonitis was defined as clinical features of peritonitis (abdominal pain or cloudy dialysate) and dialysate leucocytosis (white blood cell count > 100/lL with >50% neutrophils). Peritonitis rates were calculated according to the standardized recommendations made by the International Society of Peritoneal Dialysis (ISPD) [20] . All episodes of peritonitis that occurred while patients were receiving PD were divided by the number of days that patients were receiving PD during a nominated time period (month, season, year or study period) to yield a peritonitis rate that was expressed as episodes per patientyear at risk. In keeping with ISPD recommendations [21, 22] , relapsed peritonitis was counted as a single episode and patients with a PD catheter in situ who were not receiving PD were not included in peritonitis rate calculations.
The clinical outcomes examined were peritonitis cure, peritonitis relapse, peritonitis-associated hospitalization, catheter removal, temporary haemodialysis transfer (in which patients subsequently resumed PD), permanent haemodialysis transfer and patient death. A peritonitis episode was considered 'cured' by antibiotics alone if the patient was symptom free, the PD effluent was clear and the episode was not complicated by relapse, catheter removal or death. Peritonitis-related death was recorded if the patient's death was directly attributable to peritonitis in the clinical opinion of the treating nephrologist. In view of the complexities associated with analysis of multiple events within individuals where the assumption of independence of observations is not appropriate, the primary outcomes analyses included only the first episodes of peritonitis from each individual. Clinical outcomes for all episodes of peritonitis were examined as secondary analyses.
Statistical analysis
Results were expressed as frequencies and percentages, mean AE SD or median [25th À 75th percentile], as appropriate. Differences between groups were analysed by chi-square test for categorical data, analysis of variance for continuous normally distributed data and Kruskal-Wallis test for continuous non-normally distributed data. Peritonitis rates according to month or season were compared by Poisson regression analysis. The independent predictors of the clinical outcomes of peritonitis were determined by multivariate logistic regression. Season of first peritonitis occurrence, age, gender, racial origin, BMI, estimated glomerular filtration rate at dialysis start, late referral within 3 months of dialysis commencement, end-stage renal failure cause, smoking status, comorbidities, peritoneal transport status and initial empiric antibiotic regimen were included in the model as covariates. First-order interaction terms between the significant covariates were examined, where appropriate. Data were analysed using the software packages PASW Statistics for Windows release 18.0 (SPSS Inc., North Sydney, Australia). P-values <0.05 were considered statistically significant.
Results
Population characteristics
A total of 6610 patients received PD in Australia during the study period (1 October 2003 to 31 December 2008) and were followed for 10 470 patient-years (mean follow-up 1.58 years per patient). Their characteristics are depicted in Table 1 . In this group, 6213 episodes of peritonitis occurred in 3128 (47%) patients (range 1-15 episodes per patient). The overall rate of peritonitis was 0.59 episodes per patient-year of treatment (equivalent to 20.2 patient-months per episode).
Seasonal variation in peritonitis rate
The calculated peritonitis rates for each calendar month of the study period are shown in Figure 1 . When data were grouped according to seasons, no significant seasonal variation was observed (Table 3) 
Seasonal variation in peritonitis microbiology
The microbiological causes of all episodes of peritonitis during the study period are summarized in Table 2 . The proportions of organisms isolated from all peritonitis episodes were not significantly different from those of first peritonitis episodes (P ¼ 0. 3) When the rates of all peritonitis due to specific microorganisms were analysed according to their season of occurrence, significant seasonal variations were observed in the rates of peritonitis caused by coagulase-negative Staphylococci (spring and summer peaks), Corynebacteria (winter peak) and Gram-negative organisms (summer and autumn peaks) (Table 2, Figure 3 ). There were also strong trends to seasonal variations in peritonitis rates due to fungi (summer and autumn peaks) and pseudomonas (summer peak) (Table 2, Figure 3d ). No significant seasonal variations were observed in the rates of PD peritonitis due to Staphylococcus aureus, Streptococci, Enterococci, polymicrobial organisms or culture-negative infection.
When subgroup analyses were performed in PD patients living in tropical regions (n ¼ 411) and temperate regions (n ¼ 4236) of Australia to determine whether seasonal variations were more prominent at the extremes of climate, no significant seasonal variations in overall peritonitis rates were observed (Table 3 ). Although these analyses had limited statistical power, significant seasonal variations were found for coagulase-negative staphylococcal peritonitis (spring peak) in tropical regions and for corynebacterial peritonitis (winter peak) and Gram-negative peritonitis (summer and autumn peaks) in temperate regions (Table 3) .
Seasonal variation in outcomes of first peritonitis episodes
Clinical outcomes of first peritonitis episodes occurring in different seasons were generally similar, with no significant differences observed between the four groups (Table 4) . Using multivariable logistic regression, season of peritonitis occurrence did not independently predict any clinical outcomes, including cure ( Table 4) .
When all peritonitis episodes were examined, winter peritonitis episodes were associated with significantly shorter hospital stays and lower probabilities of catheter removal and permanent haemodialysis transfer on univariate analysis (Table 5 ). However, no significant seasonal variation in peritonitis outcomes was identified following multivariable adjustment for demographic and clinical factors (including causative micro-organism).
Discussion
The present study represents the largest and only multi-centre examination to date of the effect of season on the frequency and clinical outcomes of PD-associated peritonitis. While significant seasonal variations were not observed in overall PD peritonitis rates or peritonitis outcomes, there were significant seasonal variations in organism-specific peritonitis rates with peaks in the incidence of PD peritonitis caused by coagulase-negative staphylococci and Gram-negative organisms in warmer seasons and Corynebacterium species in winter. Fungi also tended to be more common in the warmer seasons (summer and autumn). There were no significant seasonal variations in the rates of PD peritonitis due to Staphylococcus aureus, Streptococci, Enterococci, polymicrobial organisms or culture-negative infections.
In contrast to the current study findings, a number of investigations [15] [16] [17] have previously demonstrated significant seasonal variations in overall PD peritonitis rates whereby peritonitis episodes were more frequent in the [16, 18] , Korea [15] and Brazil [17] , which have identified significant seasonal variations in peritonitis. The current investigation involved all PD patients from over 70 PD centres exposed to relatively warm and humid conditions, which vary considerably according to season. This greatly enhanced the ability to identify any seasonal variations in peritonitis rates. Indeed, significant seasonal variations were observed in the rates of peritonitis caused by specific microorganisms. In particular, coagulase-negative Staphylococci, Gramnegative organisms, fungi and pseudomonas were more frequent in warmer seasons (Table 3 ). The mechanisms underpinning these observations may be related to host or organism-related factors. Heat-or humidity-related increases in skin perspiration and changes in human behaviour during warmer seasons, where more people may participate in outdoor activities such as swimming in oceans or waterholes, may have contributed to higher organism-specific PD peritonitis rates. This may be particularly relevant for organisms, such as coagulase-negative Staphylococci, that typically reside on healthy human skin and mucus membranes. Increases in PD peritonitis and systemic infections from Gram-negative organisms in association with a rise in temperature have been described [16, 18, 23, 24] . Such associations appear to be independent of the source of the bacteria acquisition, such as the environment (e.g. Acinetobacter species, Pseudomonas aeruginosa) or the host (e.g. human commensal species such as Escherichia coli). For environmentally acquired bacteria, it is postulated that rises in temperature have a direct effect on organism survival and multiplication resulting in increased density and likelihood of infection [25] . The temperature may also affect virulence of pathogens. For example, Candida species, which are responsible for majority of fungal peritonitis in Australia [11] , have been shown to develop tubular, branching hyphal cells in response to temperature rises, which facilitates deep penetration of human tissues compared to the unicellular budding yeast state observed in cooler conditions [26] .
In contrast to the other pathogens examined in this study, corynebacterial PD peritonitis peaked during winter (Table 3 ).
The reasons for this observation are uncertain although corynebacterial infections are particularly observed in immunocompromised patients [27] and seasonal variations in immune function have been previously reported with decreased levels during the winter [28] . It is therefore conceivable that peaks in corynebacterial peritonitis coincide with winter-related declines in the immune status of PD patients.
In keeping with the findings of previous studies [16, 18] , there was no significant seasonal variation in PD peritonitis due Staphylococcus aureus in the present study. This may have been due to the demonstrated lack of seasonal variation in the number of Staphylococcus aureus colonies on the skin of human beings, either with or without skin conditions [29] .
The strengths of this study include its very large sample size and inclusiveness. We included all patients receiving PD in Australia during the study period, such that a variety of centres was included with varying approaches to the microbiological diagnosis and treatment of peritonitis. This greatly enhanced the external validity of our findings. These strengths should be balanced against the study's limitations, which included limited depth of data collection. ANZDATA does not collect important information, such as the presence of concomitant exit site and tunnel infections, antimicrobial susceptibilities of isolated microorganisms, patient compliance, socio-economic status, individual unit management protocols (including the approaches to relapsed and recurrent peritonitis and nasal staphylococcal colonization), duration of cloudy dialysate, laboratory values (such as C-reactive protein and dialysate white cell counts), severity of comorbidities, PD modality (ambulatory or continuous ambulatory PD) at time of peritonitis, disconnect systems used, prescribed PD dialysate (especially icodextrin), antibiotic dosages or routes of antibiotic administration, peritoneal dialysate culture methodology, previous antibiotic exposure for any indication or local centre monthly or seasonal temperature and humidity data. Even though we adjusted for a large number of patient characteristics, the possibility of residual confounding could not be excluded. In common with other registries, ANZDATA is a voluntary registry and there is no external audit of data accuracy, including the diagnosis of peritonitis. Consequently, the possibility of coding/classification bias cannot be excluded.
In conclusion, our study represents the largest examination to date and the first comprehensive multi-centre evaluation of the effects of season on the frequency and clinical outcomes of PD-associated peritonitis. The principal findings were that seasonal variation did not appreciably influence overall PD peritonitis rates or clinical outcomes. Nevertheless, significant seasonal variations were observed in the rates of peritonitis due to specific microorganisms, such as coagulase-negative Staphylococci, Corynebacteria, Gram-negative organisms and fungi. This information may allow institutions to reinforce implementation of evidencebased infection control strategies (e.g. anti-fungal prophylaxis) prior to higher risk seasons.
